Financial News
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
March 03, 2024 at 07:48 AM EST
Some Wall Street analysts said Viking's experimental obesity treatment may be "best-in-class" following the release of midstage trial data.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
